Literature DB >> 9788961

Angiotensin induces the urinary peristaltic machinery during the perinatal period.

Y Miyazaki1, S Tsuchida, H Nishimura, J C Pope, R C Harris, J M McKanna, T Inagami, B L Hogan, A Fogo, I Ichikawa.   

Abstract

The embryonic development of mammalian kidneys is completed during the perinatal period with a dramatic increase in urine production, as the burden of eliminating nitrogenous metabolic waste shifts from the placenta to the kidney. This urine is normally removed by peristaltic contraction of the renal pelvis, a smooth muscle structure unique to placental mammals. Mutant mice completely lacking angiotensin type 1 receptor genes do not develop a renal pelvis, resulting in the buildup of urine and progressive kidney damage. In mutants the ureteral smooth muscle layer is hypoplastic and lacks peristaltic movements. We show that angiotensin can induce the ureteral smooth muscles in organ cultures of wild-type, but not mutant, ureteral tissues and that, in wild-type mice, expression of both renal angiotensin and the receptor are transiently upregulated at the renal outlet at birth. These results reveal a new role for angiotensin in the unique cellular adaptations of the mammalian kidney to the physiological stresses of postnatal life.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788961      PMCID: PMC508998          DOI: 10.1172/JCI4401

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Tissue-specific expression of type 1 angiotensin II receptor subtypes. An in situ hybridization study.

Authors:  J M Gasc; S Shanmugam; M Sibony; P Corvol
Journal:  Hypertension       Date:  1994-11       Impact factor: 10.190

2.  Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia.

Authors:  T Sugaya; S Nishimatsu; K Tanimoto; E Takimoto; T Yamagishi; K Imamura; S Goto; K Imaizumi; Y Hisada; A Otsuka
Journal:  J Biol Chem       Date:  1995-08-11       Impact factor: 5.157

3.  Male-female differences in fertility and blood pressure in ACE-deficient mice.

Authors:  J H Krege; S W John; L L Langenbach; J B Hodgin; J R Hagaman; E S Bachman; J C Jennette; D A O'Brien; O Smithies
Journal:  Nature       Date:  1995-05-11       Impact factor: 49.962

4.  Renin-angiotensin system in neonatal rats: induction of a renal abnormality in response to ACE inhibition or angiotensin II antagonism.

Authors:  P Friberg; B Sundelin; S O Bohman; A Bobik; H Nilsson; A Wickman; H Gustafsson; J Petersen; M A Adams
Journal:  Kidney Int       Date:  1994-02       Impact factor: 10.612

5.  Glomerular angiotensin II receptor subtypes during development of rat kidney.

Authors:  G M Ciuffo; M Viswanathan; A M Seltzer; K Tsutsumi; J M Saavedra
Journal:  Am J Physiol       Date:  1993-08

6.  Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype.

Authors:  J Sadoshima; S Izumo
Journal:  Circ Res       Date:  1993-09       Impact factor: 17.367

7.  Regulation of blood pressure by the type 1A angiotensin II receptor gene.

Authors:  M Ito; M I Oliverio; P J Mannon; C F Best; N Maeda; O Smithies; T M Coffman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

Review 8.  Recognition and management of angiotensin converting enzyme inhibitor fetopathy.

Authors:  A B Sedman; D B Kershaw; T E Bunchman
Journal:  Pediatr Nephrol       Date:  1995-06       Impact factor: 3.714

9.  Angiotensin-converting enzyme inhibitor fetopathy.

Authors:  P G Pryde; A B Sedman; C E Nugent; M Barr
Journal:  J Am Soc Nephrol       Date:  1993-03       Impact factor: 10.121

10.  Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.

Authors:  Y Gavrieli; Y Sherman; S A Ben-Sasson
Journal:  J Cell Biol       Date:  1992-11       Impact factor: 10.539

View more
  41 in total

Review 1.  Local renin-angiotensin systems in the genitourinary tract.

Authors:  Craig Comiter
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-11-13       Impact factor: 3.000

Review 2.  Development of the kidney medulla.

Authors:  Renfang Song; Ihor V Yosypiv
Journal:  Organogenesis       Date:  2012-01-01       Impact factor: 2.500

3.  Angiotensin II regulates growth of the developing papillas ex vivo.

Authors:  Renfang Song; Graeme Preston; Ali Khalili; Samir S El-Dahr; Ihor V Yosypiv
Journal:  Am J Physiol Renal Physiol       Date:  2012-02-01

Review 4.  Genetic and developmental basis for urinary tract obstruction.

Authors:  Feng Chen
Journal:  Pediatr Nephrol       Date:  2008-12-16       Impact factor: 3.714

5.  Plumbing the depths of urinary tract obstruction by using murine models.

Authors:  Feng Chen
Journal:  Organogenesis       Date:  2009-01       Impact factor: 2.500

Review 6.  Wnt signaling and renal medulla formation.

Authors:  Jing Yu
Journal:  Pediatr Nephrol       Date:  2011-05-01       Impact factor: 3.714

Review 7.  Renin-angiotensin system-growth factor cross-talk: a novel mechanism for ureteric bud morphogenesis.

Authors:  Ihor V Yosypiv
Journal:  Pediatr Nephrol       Date:  2008-10-29       Impact factor: 3.714

Review 8.  Obstructive nephropathy: insights from genetically engineered animals.

Authors:  Jean-Loup Bascands; Joost P Schanstra
Journal:  Kidney Int       Date:  2005-09       Impact factor: 10.612

Review 9.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

10.  Angiotensin II promotes development of the renal microcirculation through AT1 receptors.

Authors:  Kirsten Madsen; Niels Marcussen; Michael Pedersen; Gitte Kjaersgaard; Carie Facemire; Thomas M Coffman; Boye L Jensen
Journal:  J Am Soc Nephrol       Date:  2010-01-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.